#ICM-Quizz #MedEd A 63-year-old man developed septic shock and multiple organ failure three days after a dog bite, with widespread purpura and rods in neutrophils on blood smear. Which organism is the most likely culprit?

✨📄 What about the untapped therapeutic potential of the immune response in invasive aspergillosis ? Here’s some rational, pre-clinical and clinical evidence. Huge thanks to our amazing 🌍 team! 🔗 bit.ly/46kajHr @simonfeys.bsky.social @agocarvalho.bsky.social @martinhoenigl.bsky.social

New Medical Study Starting Soon 🔬 The logo was designed in collaboration with Galactic Partners, with professional support from Esra Sedik. Follow us for more! @martinhoenigl.bsky.social @agocarvalho.bsky.social @simonfeys.bsky.social

Viral reactivations and fungal infections in nonresolving acute respiratory distress syndrome CCR Journal Watch https://criticalcarereviews.com/latest-evidence/journal-watch

YECMM is planning a 🍄 get-together during #ESCMIDglobal2025 ! Are you a young clinician/scientist interested in mycology ? Join us on Saturday 12/04 in #Vienna 🇦🇹. 👉 RSVP: forms.gle/spTQGnWfjd11...

Super happy to be part of this team investigating genetics in influenza-associated aspergillosis! Now we just need a logo…

Martin Hoenigl@martinhoenigl.bsky.social · 2y ago

Kickoff meeting for the 🌌Galectin-3 targeted antifungal prophylaxis in ICU influenza (GALActIC)🌌 eppermed.eu project at UZLeuven Incredibly productive meeting with the Galactic team @agocarvalho.bsky.social @simonfeys.bsky.social @msgerc.bsky.social @ishamycology.bsky.social

🆕 Few thoughts we wanted to share with the community to look at 🍄 #aspergillosis diagnosis from a different perspective when we are still struggling on the topic. w/ @simonfeys.bsky.social @agocarvalho.bsky.social & cie Actively working on more answers. Stay tuned. 👉 doi.org/10.1016/j.cm...